P2-proline-derived inhibitors of calpain I

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 19, 1998, Pages 2647-2652

  Tripathy, Rabindranath ^a   Gu, Zi Qiang ^a   Dunn, Derek ^a   Senadhi, Shobha E ^a   Ator, Mark A ^a   Chatterjee, Sankar ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPAIN 1 INHIBITOR; CATHEPSIN B; CHYMOTRYPSIN A; PROLINE DERIVATIVE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE INHIBITOR; DRUG DERIVATIVE; PROLINE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; CHEMISTRY; DRUG ANTAGONISM; HUMAN; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CALPAIN; CYSTEINE PROTEINASE INHIBITORS; HUMANS; PROLINE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032491079     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00470-3     Document Type: Article

References (19)

1. 1. Croall, D. L.; DeMartino, G. N. Physiol. Rev. 1991, 77, 813.
2. 2. Wang, K. K. W.; Yuen, P. Trends Pharm. Sci. 1994, 15, 412.
3. 3. Iqbal, M.; Messina, P. A.; Freed, B.; Das, M.; Chatterjee, S.; Tripathy, R.; Tao, M.; Josef, K. A.; Dembofsky, B.; Dunn, D.; Griffith, E.; Siman, R.; Senadhi, S. E.; Biazzo, W.; Bozyczko-Coyne, D.; Meyer, S. L.; Ator, M. A.; Bihovsky, R. Bioorg. Med. Chem. Lett. 1997, 7, 539.
4. 4. Mehdi, S. Trends Biol. Sci. 1991, 16, 150.
5. 5. Harbeson, S. L.; Abelleira, S. M.; Akiyama, A.; Barrett, R., III,; Carroll, R. M.; Straub, J. A.; Tkacz, J. N.; Wu, C.; Musso, G. F. J. Med. Chem. 1994, 37, 2918.
6. 6. (a) Li, Z.; Patil, G. S.; Golubski, Z. E.; Hori, H.; Tehrani, K.; Foreman, J. E.; Eveleth, D. D.; Bartus, R. T.; Powers, J. C. J. Med. Chem. 1993, 36, 3472.
7. (b) Li, Z.; Ortega-Vilain, A-C.; Patil, G. S.; Chu, D-L.; Foreman, J. E.; Eveleth, D. D.; Powers, J. C. J. Med Chem. 1996, 39, 4089.
8. 7. (a) Chatterjee, S.; Josef, K.; Wells, G.; Iqbal, M.; Bihovsky, R.; Mallamo, J. P.; Ator, M. A.; Bozyczko-Coyne, D.; Mallya, S.; Senadhi, S.; Siman, S. Bioorg. Med. Chem. Lett. 1996, 6, 1237.
9. (b) Chatterjee, S.; Ator, M. A.; Bozyczko-Coyne, D.; Josef, K.; Wells, G.; Tripathy, R.; Iqbal, M.; Bihovsky, R.; Senadhi, S. E.; Mallya, S.; O'Kane, T. M.; McKenna, B. A.; Siman, R.; Mallamo, J. P. J. Med. Chem. 1997, 40, 3820.
10. 8. Angliker, H.; Anagli, J.; Shaw, E. J. Med. Chem. 1992, 35, 216.
11. 9. Crawford, C.; Mason, R. W.; Wickstrom, P.; Shaw, E. Biochem. J. 1988, 253, 751.
12. 10. McGowan, E. B.; Becker, E.; Detwiler, T. C. Biochem. Biophys. Res. Commun. 1989,158, 432.
13. 11. Huang, Z.; McGowan, E. B.; Detwiler, T. C. J. Med. Chem. 1992, 35, 2048.
14. 12. Harris, A. L.; Gregory, J. S.; Maycock, A. L.; Graybill, T. L.; Osifo, I. K.; Schmidt, S. L.; Dolle, R. E. Bioorg. Med. Chem. Lett. 1995, 5, 393.
15. 13. Chatterjee, S.; Gu, Z-Q.; Dunn, D.; Tao, M.; Josef, K.; Tripathy, R.; Bihovsky, R.; Senadhi, S. E.; O'Kane, T. M.; McKenna, B. A.; Mallya, S.; Ator, M. A.; Bozyczko-Coyne, D.; Siman, R.; Mallamo, J. P. J. Med. Chem. 1998, 41, 2663.
16. 14. Hosoda et al. mentioned Cbz-L-Pro-derived inhibitors in a patent application (Patent Application No. JP93-345753, 1993-12-27; Assignee: Fujirebio).
17. 15. Synthetic details will be published in the full account of this work.
18. 16. Meyer, S. L.; Bozyczko-Coyne, D.; Mallya, S. K.; Spais, C. M.; Bihovsky, R.; Kawooya, J. K.; Lang, D. M.; Scott, R. W; Siman, R. Biochem. J. 1996, 314, 511.
19. 17. Kempf, D. J.; Molla, A.; Marsh, K. C.; Park, C.; Rodrigues, A. D.; Korneyeva, M.; Vasavanonda, S.; McDonald, E.; Flentge, C. A.; Muchmore, S.; Wideburg, N. E.; Saldivar, A.; Cooper, A.; Kati, W. M.; Stewart, K. D.; Norbeck, D. W. Bioorg. Med. Chem. Lett. 1997, 7, 699.